Bioinformatics analysis of colorectal cancer transcriptomic data reveals novel prognostic signature and potential biomarker genes

dc.contributor.authorDalkilic, Semih
dc.contributor.authorDalkilic, Lutfiye Kadioglu
dc.contributor.authorUygur, Lutfu
dc.contributor.authorTimurkaan, Mustafa
dc.contributor.authorGulturk, Baris
dc.contributor.authorKaplan, Mustafa
dc.date.accessioned2026-08-12T17:21:40Z
dc.date.issued2025
dc.departmentFırat Üniversitesi
dc.description.abstractObjectiveColorectal cancer (CRC) is a type of digestive system cancer. At the molecular level, some factors, including genetic and epigenetic factors, as well as various signaling pathways such as oxidative stress and inflammation, play an active role in the onset of CRC. Genetic and epigenetic mutations, particularly in oncogenes and tumor suppressor genes, occur during colorectal adenocarcinoma development as a result of a change in gastrointestinal epithelial cell proliferation and self-renewal rates. This study aimed to determine the genes and molecular mechanisms that play a role in the emergence of this disease by analyzing the CRC data.Material and methodsMicroarray data selected for bioinformatics analysis is Gene Expression data stored with the code GSE110224 in the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus (GEO) database. Gene expression analysis, functional clustering analysis, enrichment analysis, and pathway analysis were performed using this data set.ResultsAnalysis of raw transcriptomic data revealed 1770 common DEGs in CRC. While the expression level of 769 of these genes increased, the expression level of 1001 genes decreased. A Protein-protein interaction (PPI) network was created from the first 25 genes with increased expression levels and 11 signature genes were identified. Increased expression of REG1A, MMP3, FOXQ1 and CEMIP genes and decreased expression of AQP8, CA1, CLDN8, PYY, CA4, CEACAM7 and SLC30A10 genes were observed.ConclusionsThis approach revealed a CRC-specific molecular profile and may provide some guidance for further investigation of potential biomarkers for diagnosis and prognosis prediction of CRC patients.
dc.identifier.doi10.1080/00365521.2024.2437437
dc.identifier.endpage53
dc.identifier.issn0036-5521
dc.identifier.issn1502-7708
dc.identifier.issue1
dc.identifier.orcid0000-0002-5113-2703
dc.identifier.orcid0000-0003-3413-312X
dc.identifier.orcid0000-0003-1950-0489
dc.identifier.orcid0000-0002-6892-247X
dc.identifier.pmid39644158
dc.identifier.scopus2-s2.0-85211212218
dc.identifier.scopusqualityQ3
dc.identifier.startpage42
dc.identifier.urihttps://doi.org/10.1080/00365521.2024.2437437
dc.identifier.urihttps://hdl.handle.net/11508/54022
dc.identifier.volume60
dc.identifier.wosWOS:001371906800001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor & Francis Ltd
dc.relation.ispartofScandinavian Journal of Gastroenterology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectColorectal cancer
dc.subjectgene expression
dc.subjectanalysis
dc.subjectbioinformatics
dc.subjectbiomarkers
dc.titleBioinformatics analysis of colorectal cancer transcriptomic data reveals novel prognostic signature and potential biomarker genes
dc.typeArticle

Dosyalar